ReviewCancer metastasis reviews2025

VCAM-1 as a common biomarker in inflammatory bowel disease and colorectal cancer: unveiling the dual anti-inflammatory and anti-cancer capacities of anti-VCAM-1 therapies.

Jessica R Pickett et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.